132 related articles for article (PubMed ID: 15957606)
21. [Differential diagnosis of cone dystrophies].
Sadowski B; Zrenner E
Ophthalmologe; 1994 Dec; 91(6):719-29. PubMed ID: 7849422
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
[TBL] [Abstract][Full Text] [Related]
23. Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.
Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
Doc Ophthalmol; 2016 Jun; 132(3):157-66. PubMed ID: 27033713
[TBL] [Abstract][Full Text] [Related]
24. A novel Gly35Ser mutation in the RDH5 gene in a Japanese family with fundus albipunctatus associated with cone dystrophy.
Wada Y; Abe T; Sato H; Tamai M
Arch Ophthalmol; 2001 Jul; 119(7):1059-63. PubMed ID: 11448328
[TBL] [Abstract][Full Text] [Related]
25. Full-field electroretinograms in miniature poodles with progressive rod-cone degeneration.
Sandberg MA; Pawlyk BS; Berson EL
Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1179-84. PubMed ID: 3721798
[TBL] [Abstract][Full Text] [Related]
26. A naturally occurring rat model of X-linked cone dysfunction.
Gu YH; Zhang ZM; Long T; Li L; Hou BK; Guo Q
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5321-6. PubMed ID: 14638733
[TBL] [Abstract][Full Text] [Related]
27. The enhanced S cone syndrome: an analysis of receptoral and post-receptoral changes.
Greenstein VC; Zaidi Q; Hood DC; Spehar B; Cideciyan AV; Jacobson SG
Vision Res; 1996 Nov; 36(22):3711-22. PubMed ID: 8977001
[TBL] [Abstract][Full Text] [Related]
28. An electroretinographic and molecular genetic study of X-linked cone degeneration.
Reichel E; Bruce AM; Sandberg MA; Berson EL
Am J Ophthalmol; 1989 Nov; 108(5):540-7. PubMed ID: 2554733
[TBL] [Abstract][Full Text] [Related]
29. Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.
Ko AC; Hernández J; Brinton JP; Faidley EA; Mugge SA; Mets MB; Kardon RH; Folk JC; Mullins RF; Stone EM
Arch Ophthalmol; 2010 Dec; 128(12):1590-5. PubMed ID: 21149784
[TBL] [Abstract][Full Text] [Related]
30. A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction.
Barnes CS; Alexander KR; Fishman GA
Ophthalmology; 2002 Mar; 109(3):575-83. PubMed ID: 11874764
[TBL] [Abstract][Full Text] [Related]
31. Cone loss is delayed relative to rod loss during induced retinal degeneration in the diurnal cone-rich rodent Arvicanthis ansorgei.
Boudard DL; Tanimoto N; Huber G; Beck SC; Seeliger MW; Hicks D
Neuroscience; 2010 Sep; 169(4):1815-30. PubMed ID: 20600653
[TBL] [Abstract][Full Text] [Related]
32. S-cone function in patients with retinitis pigmentosa.
Swanson WH; Birch DG; Anderson JL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3045-55. PubMed ID: 8407212
[TBL] [Abstract][Full Text] [Related]
33. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.
Aleman TS; Cideciyan AV; Volpe NJ; Stevanin G; Brice A; Jacobson SG
Exp Eye Res; 2002 Jun; 74(6):737-45. PubMed ID: 12126946
[TBL] [Abstract][Full Text] [Related]
34. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
Birch DG; Anderson JL; Fish GE
Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
[TBL] [Abstract][Full Text] [Related]
35. Topography of cone electrophysiology in the enhanced S cone syndrome.
Marmor MF; Tan F; Sutter EE; Bearse MA
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1866-73. PubMed ID: 10393063
[TBL] [Abstract][Full Text] [Related]
36. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
37. 'Unilateral cone dystrophy': ERG changes implicate abnormal signaling by hyperpolarizing bipolar and/or horizontal cells.
Sieving PA
Trans Am Ophthalmol Soc; 1994; 92():459-71; discussion 471-4. PubMed ID: 7886877
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against human retinal proteins in serum from patients with cone dystrophy.
Isashiki Y; Ohba N; Nakagawa M; Miyake Y
Jpn J Ophthalmol; 1992; 36(3):323-30. PubMed ID: 1464972
[TBL] [Abstract][Full Text] [Related]
39. Cone dystrophy or macular dystrophy associated with novel autosomal dominant
Manes G; Mamouni S; Hérald E; Richard AC; Sénéchal A; Aouad K; Bocquet B; Meunier I; Hamel CP
Mol Vis; 2017; 23():198-209. PubMed ID: 28442884
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 19q cone-rod retinal dystrophy. Ocular phenotype.
Evans K; Duvall-Young J; Fitzke FW; Arden GB; Bhattacharya SS; Bird AC
Arch Ophthalmol; 1995 Feb; 113(2):195-201. PubMed ID: 7864751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
